Liu He

Liu He

Auto-generated profile, based on publicly available information

Liu He

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2019 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
CLChang Liu
Chang Liu
XDXin Du
Xin Du
CJChao Jiang
Chao Jiang
LHLiu He
Liu He
SCSan-Shuai Chang
San-Shuai Chang
CMChangsheng Ma
Changsheng Ma
BACKGROUND:Oral anticoagulants (OACs) such as warfarin and non-VKA oral anticoagulants (NOACs) have been recommended for patients with atrial fibrillation (AF) who are at risk for stroke. Whether NOACs have a higher persistence than warfarin is still...

5 January 2021 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
LHLiu He
Liu He
ZDZhao-Jie Dong
Zhao-Jie Dong
XDXin Du
Xin Du
CJChao Jiang
Chao Jiang
Ning ChenNing Chen
Ning Chen
CMChangsheng Ma
Changsheng Ma
Aims This study sought to compare healthcare quality and 30 day, 90 day, and 1 year mortality rates among patients admitted to secondary and tertiary hospitals for heart failure (HF) in Beijing. Methods and results This study retrospectively enrolled patients hospitalized with a primary discharge diagnosis of HF during January 2014 to December 2015, from five tertiary and four secondary hospitals, in Beijing, China. Mortality data were extracted from Beijing Death Surveillance Database. HF healthcare quality indices were used to evaluate in‐hospital care. Associations between hospital level and mortality rates were assessed using generalized linear mixed models, adjusting for patients' baseline characteristics and intra‐hospital correlation. Data from 1413 patients (median [interquartile range] age = 74 [65–80] years, 52.7% female) from secondary hospitals and 1250 patients (median [interquartile range] age = 72 [61–79] years, 43.3% female) from tertiary hospitals were collected. Rates of left ventricular ejection fraction assessment (73.2% vs. 90.1%) and combined use of β‐blockers and angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers (30.1% vs. 49.3%) were lower in secondary hospitals than those in tertiary hospitals, respectively. Patients admitted to secondary hospitals had a higher 90 day mortality [10.8% vs. 5.0%; adjusted odds ratio (OR): 2.06; 95% confidence interval (CI): 1.10–3.84, P = 0.024 and a higher 1 year mortality rate [21.0% vs. 12.1%; adjusted OR: 1.64; 95% CI: 1.02–2.62, P = 0.039], but 30 day mortality rates were not significantly different (5.5% vs. 3.0%; adjusted OR: 1.49; 95% CI: 0.63–3.52, P = 0.368). Conclusions Worse quality of care for patients with HF in secondary hospitals was associated with higher 90 day and 1 year mortality rates. Improving care quality in secondary hospitals is crucial to improve prognosis of patients they served.

1 May 2021 in JACC
Verified
Journal Article
Closed access
ZDZhaojie Dong
Zhaojie Dong
XDXin Du
Xin Du
CJChao Jiang
Chao Jiang
SXshijun xia
shijun xia
LHLiu He
Liu He
CMChangsheng Ma
Changsheng Ma